08/30/2026
Do continuous glucose monitors (CGMs) impact hyperinsulinism (HI) care?
✅ Among participants currently using a CGM:
🔹 82% reported that CGM data led to adjustments in their treatment plan (e.g., medication dose/timing, prescribed feeding schedule) and/or daily routine (e.g., snack before activity, avoiding certain activities).
✅ Hypoglycemia prevention actions:
🔹 84% take at least one preventive action every day (e.g. eating food and/or taking medication to prevent a low)
🔹 40% report an average of four or more preventive actions daily
These findings show how CGMs can play a key role in managing HI and preventing dangerous lows.
These insights and more are featured in our 2025 HI Global Registry Annual Report, available at https://congenitalhi.org/higr-annual-reports-and-publications/
What is HIGR? It’s the only patient-powered hyperinsulinism (HI) registry, and your input drives critical research.
Not registered yet? It’s not too late to share your experiences and feel the power of your data! Learn more at higlobalregistry.org at the link in our bio and sign up today.
| Hyperinsulinism | Congenital | HI | Hypoglycemia | Rare Disease